A safe, effective, herbal antischistosomal therapy derived from myrrh.

Z SheirDepartment of Internal Medicine, Faculty of Medicine, Students' University Hospital, Mansoura University, Egypt.

Search for other papers by Z Sheir in
Current site
Google Scholar
PubMed
Close
,
A A NasrDepartment of Internal Medicine, Faculty of Medicine, Students' University Hospital, Mansoura University, Egypt.

Search for other papers by A A Nasr in
Current site
Google Scholar
PubMed
Close
,
A MassoudDepartment of Internal Medicine, Faculty of Medicine, Students' University Hospital, Mansoura University, Egypt.

Search for other papers by A Massoud in
Current site
Google Scholar
PubMed
Close
,
O SalamaDepartment of Internal Medicine, Faculty of Medicine, Students' University Hospital, Mansoura University, Egypt.

Search for other papers by O Salama in
Current site
Google Scholar
PubMed
Close
,
G A BadraDepartment of Internal Medicine, Faculty of Medicine, Students' University Hospital, Mansoura University, Egypt.

Search for other papers by G A Badra in
Current site
Google Scholar
PubMed
Close
,
H El-ShennawyDepartment of Internal Medicine, Faculty of Medicine, Students' University Hospital, Mansoura University, Egypt.

Search for other papers by H El-Shennawy in
Current site
Google Scholar
PubMed
Close
,
N HassanDepartment of Internal Medicine, Faculty of Medicine, Students' University Hospital, Mansoura University, Egypt.

Search for other papers by N Hassan in
Current site
Google Scholar
PubMed
Close
, and
S M HammadDepartment of Internal Medicine, Faculty of Medicine, Students' University Hospital, Mansoura University, Egypt.

Search for other papers by S M Hammad in
Current site
Google Scholar
PubMed
Close

Schistosomiasis is a widespread helminthic disease. Treatment of schistosomiasis is based on chemotherapy with praziquantel, which is the drug of choice. Since resistance to praziquantel has been demonstrated, alternative drugs must be considered. Myrrh is an oleo-gum resin from the stem of the plant Commiphora molmol. This study was carried out on 204 patients with schistosomiasis. The drug was given at a dose of 10 mg/kg of body weight/day for three days, and induced a cure rate of 91.7%. Re-treatment of cases who did not respond with a dose of 10 mg/kg of body weight/day for six days gave a cure rate of 76.5%, increasing the overall cure rate to 98.09%. The drug was well tolerated, and side effects were mild and transient. Twenty cases provided biopsy specimens six months after treatment and none of them showed living ova.

Save